Zydus Lifesciences Ltd.

Cadila Healthcare has informed that the meeting of the Board of Directors of the Company will be held on Thursday, February 3, 2022 to consider apart from other agenda items to approve the unaudited financial results for the quarter / nine months ended on December 31, 2021. The trading window as per the SEBI (Prohibition of Insider Trading) Regulations, 2015 shall remain closed till February 6, 2022 and shall open for trading on and from February 7, 2022 for all the Directors and Designated Persons.

The above information is a part of company’s filings submitted to BSE.